{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:28:55Z","timestamp":1792114135830,"version":"4.4.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100020975","name":"UCB Pharma France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020975","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s00415-024-12714-5","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T12:11:09Z","timestamp":1728562269000},"page":"7239-7249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Treatment of myasthenia gravis in france: A retrospective claims database study (STAMINA)"],"prefix":"10.1007","volume":"271","author":[{"given":"C.","family":"Tard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Laforet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"de Pouvourville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Crochard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Chollet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Nevoret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6838-2680","authenticated-orcid":false,"given":"S.","family":"Bou\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Salort-Campana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"key":"12714_CR1","first-page":"874680","volume":"2012","author":"A Jayam Trouth","year":"2012","unstructured":"Jayam Trouth A, Dabi A, Solieman N, Kurukumbi M, Kalyanam J (2012) Myasthenia gravis: a review. Autoimmune Dis 2012:874680\u2013874680","journal-title":"Autoimmune Dis"},{"issue":"2","key":"12714_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ncl.2018.01.004","volume":"36","author":"MH Rivner","year":"2018","unstructured":"Rivner MH, Pasnoor M, Dimachkie MM, Barohn RJ, Mei L (2018) Muscle-specific tyrosine kinase and myasthenia gravis owing to other antibodies. Neurol Clin 36(2):293\u2013310","journal-title":"Neurol Clin"},{"issue":"11","key":"12714_CR3","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3389\/fneur.2020.00660","volume":"23","author":"C Rodolico","year":"2020","unstructured":"Rodolico C, Bonanno C, Toscano A, Vita G (2020) MuSK-associated myasthenia gravis: clinical features and management. Front Neurol 23(11):660","journal-title":"Front Neurol"},{"issue":"11","key":"12714_CR4","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.3390\/jcm10112235","volume":"10","author":"L Dresser","year":"2021","unstructured":"Dresser L, Wlodarski R, Rezania K, Soliven B (2021) Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations. J Clin Med 10(11):2235","journal-title":"J Clin Med"},{"issue":"4","key":"12714_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/CND.0000000000000257","volume":"20","author":"AN Boscoe","year":"2019","unstructured":"Boscoe AN, Xin H, L\u2019Italien GJ, Harris LA, Cutter GR (2019) Impact of Refractory Myasthenia Gravis on Health-Related Quality of Life. J Clin Neuromuscul Dis 20(4):173\u2013181. https:\/\/doi.org\/10.1097\/CND.0000000000000257. (PMID: 31135620; PMCID: PMC6571178)","journal-title":"J Clin Neuromuscul Dis"},{"key":"12714_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3233\/JND-140045","volume":"2","author":"JCW Deenen","year":"2015","unstructured":"Deenen JCW, Horlings CGC, Verschuuren JJGM, Verbeek ALM (2015) 2021 The epidemiology of neuromuscular disorders: a comprehensive overview of the literature. J Neuromuscul Dis 2:73\u201385","journal-title":"J Neuromuscul Dis"},{"issue":"10","key":"12714_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-2377-10-46.PMID:20565885;PMCID:PMC2905354","volume":"18","author":"AS Carr","year":"2010","unstructured":"Carr AS, Cardwell CR, McCarron PO, McConville J (2010) A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol 18(10):46. https:\/\/doi.org\/10.1186\/1471-2377-10-46.PMID:20565885;PMCID:PMC2905354","journal-title":"BMC Neurol"},{"issue":"3","key":"12714_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.neurol.2023.09.004","volume":"180","author":"E Salort-Campana","year":"2024","unstructured":"Salort-Campana E, Laforet P, de Pouvourville G, Crochard A, Chollet G, Nevoret C, Emery C, Bou\u00e9e S, Tard C (2024) Epidemiology of myasthenia gravis in France: a retrospective claims database study (STAMINA). Rev Neurol (Paris) 180(3):202\u2013210. https:\/\/doi.org\/10.1016\/j.neurol.2023.09.004. (Epub 2023 Nov 7 PMID: 37945494)","journal-title":"Rev Neurol (Paris)"},{"key":"12714_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jaut.2014.01.003","volume":"48\u201349","author":"S Berrih-Aknin","year":"2014","unstructured":"Berrih-Aknin S, Frenkian-Cuvelier M, Eymard B (2014) Diagnostic and clinical classification of autoimmune myasthenia gravis. J Autoimmun 48\u201349:143\u2013148","journal-title":"J Autoimmun"},{"issue":"1","key":"12714_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1177\/1941875210382918","volume":"1","author":"LC Wendell","year":"2011","unstructured":"Wendell LC, Levine JM (2011) Myasthenic crisis. Neurohospitalist 1(1):16\u201322","journal-title":"Neurohospitalist"},{"issue":"4","key":"12714_CR11","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","volume":"87","author":"DB Sanders","year":"2016","unstructured":"Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, Kuntz N, Massey JM, Melms A, Murai H, Nicolle M, Palace J, Richman DP, Verschuuren J, Narayanaswami P (2016) International consensus guidance for management of myasthenia gravis: executive summary. Neurology 87(4):419\u2013425","journal-title":"Neurology"},{"issue":"6","key":"12714_CR12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1602489","volume":"375","author":"GI Wolfe","year":"2016","unstructured":"Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Str\u00f6bel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BR, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Garcia Ramos GS, Verschuuren JJ, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Conwit R, Odenkirchen J, Sonett JR, Jaretzki A 3rd, Newsom-Davis J, Cutter GR (2016) Randomized trial of thymectomy in myasthenia gravis. N Engl J Med 375(6):511\u2013522","journal-title":"N Engl J Med"},{"key":"12714_CR13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1080\/08916934.2016.1214823","volume":"49","author":"JT Guptill","year":"2016","unstructured":"Guptill JT, Juel VC, Massey JM, Anderson AC, Chopra M, Yi JS et al (2016) Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis. Autoimmunity 49:472\u2013479. https:\/\/doi.org\/10.1080\/08916934.2016.1214823","journal-title":"Autoimmunity"},{"key":"12714_CR14","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/bjh.12629","volume":"164","author":"HM Reeves","year":"2014","unstructured":"Reeves HM, Winters JL (2014) The mechanisms of action of plasma exchange. Br J Haematol 164:342\u2013351. https:\/\/doi.org\/10.1111\/bjh.12629","journal-title":"Br J Haematol"},{"issue":"4","key":"12714_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/CND.0000000000000034","volume":"15","author":"NJ Silvestri","year":"2014","unstructured":"Silvestri NJ, Wolfe GI (2014) Treatment-refractory myasthenia gravis. J Clin Neuromuscul Dis 15(4):167\u2013178. https:\/\/doi.org\/10.1097\/CND.0000000000000034. (PMID: 24872217)","journal-title":"J Clin Neuromuscul Dis"},{"issue":"11","key":"12714_CR16","doi-asserted-by":"publisher","first-page":"175628561774913","DOI":"10.1177\/1756285617749134","volume":"18","author":"R Mantegazza","year":"2018","unstructured":"Mantegazza R, Antozzi C (2018) When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies. Ther Adv Neurol Disord 18(11):1756285617749134. https:\/\/doi.org\/10.1177\/1756285617749134. (Erratum.In:TherAdvNeurolDisord.2018Mar21;11:1756286418765591.PMID:29403543;PMCID:PMC5791553)","journal-title":"Ther Adv Neurol Disord"},{"key":"12714_CR17","doi-asserted-by":"crossref","unstructured":"Wiendl H, Meisel A, et al., Diagnostik und therapie myasthener syndrome, S2k-leitlinie, 2022, DGN, in: deutsche gesellschaft f\u00fcr neurologie (Hrsg.), Leitlinien f\u00fcr diagnostik und therapie in der neurologie","DOI":"10.1007\/s42451-023-00568-6"},{"key":"12714_CR18","unstructured":"Protocole National de Diagnostic et de Soins (PNDS) Myasth\u00e9nie autoimmune Juillet 2015. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2015-07\/pnds_-_myasthenie_autoimmune.pdf. Accessed 30 Sept 2024"},{"issue":"1","key":"12714_CR19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12883-022-02692-4","volume":"22","author":"L Harris","year":"2022","unstructured":"Harris L, Graham S, MacLachlan S, Exuzides A, Jacob S (2022) A retrospective longitudinal cohort study of the clinical burden in myasthenia gravis. BMC Neurol 22(1):172","journal-title":"BMC Neurol"},{"issue":"6","key":"12714_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/jnnp-2022-330519","volume":"94","author":"A Uzawa","year":"2023","unstructured":"Uzawa A, Suzuki S, Kuwabara S, Akamine H, Onishi Y, Yasuda M, Ozawa Y, Kawaguchi N, Kubota T, Takahashi MP, Suzuki Y, Watanabe G, Kimura T, Sugimoto T, Samukawa M, Minami N, Masuda M, Konno S, Nagane Y, Utsugisawa K (2023) Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis. J Neurol Neurosurg Psychiatry 94(6):467\u2013473. https:\/\/doi.org\/10.1136\/jnnp-2022-330519. (Epub 2023 Jan 24 PMID: 36693723)","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"12714_CR21","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.nmd.2023.02.002","volume":"33","author":"A Mevius","year":"2023","unstructured":"Mevius A, J\u00f6res L, Biskup J, Heidbrede T, Mahic M, Wilke T, Maywald U, Lehnerer S, Meisel A (2023) Epidemiology and treatment of myasthenia gravis: a retrospective study using a large insurance claims dataset in Germany. Neuromuscul Disord 33(4):324\u2013333","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"12714_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000529583","volume":"57","author":"H Wartmann","year":"2023","unstructured":"Wartmann H, Hoffmann S, Ruck T, Nelke C, Deiters B, Volmer T (2023) Incidence, prevalence, hospitalization rates, and treatment patterns in myasthenia gravis: a 10-year real-world data analysis of German claims data. Neuroepidemiology 57(2):121\u2013128","journal-title":"Neuroepidemiology"},{"issue":"1","key":"12714_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13023-023-02727-0","volume":"18","author":"M Mahic","year":"2023","unstructured":"Mahic M, Bozorg A, DeCourcy J, Golden K, Gibson G, Taylor C, Scowcroft A (2023) Physician- and patient-reported perspectives on myasthenia gravis in Europe: a real-world survey. Orphanet J Rare Dis 18(1):169. https:\/\/doi.org\/10.1186\/s13023-023-02727-0. (PMID:37386469;PMCID:PMC10308674)","journal-title":"Orphanet J Rare Dis"},{"issue":"17","key":"12714_CR24","doi-asserted-by":"publisher","first-page":"175628642412374","DOI":"10.1177\/17562864241237495","volume":"16","author":"J van Enkhuizen","year":"2024","unstructured":"van Enkhuizen J, Binns J, Betts A, Hosnijeh FS, Alexander M, McCormack M, Jacob S (2024) A retrospective observational study on characteristics, treatment patterns, and healthcare resource use of patients with myasthenia gravis in England. Ther Adv Neurol Disord 16(17):17562864241237496. https:\/\/doi.org\/10.1177\/17562864241237495. (PMID:38634003;PMCID:PMC11022674)","journal-title":"Ther Adv Neurol Disord"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12714-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12714-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12714-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T09:07:05Z","timestamp":1731488825000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12714-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["12714"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12714-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,10]]},"assertion":[{"value":"16 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SCE, LP, DePG, and TC received fees (advisory boards, consultation, education, presentations) from UCB. CA and CG are employees of UCB, which supported this study. NC, and BS are CEMKA employees, who received fees from UCB to conduct this analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study protocol was approved by the HDH (Health Data Hub), the National Data Protection Authority CNIL (Commission Nationale de l\u2019Informatique et des Libertes) (date of acceptation: 09\/23\/2021, reference MLD\/MFI\/AR2110968), and the National Medical Council (Conseil National de l\u2019Ordre des M\u00e9decins\u2014CNOM).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"According to HDH and CNIL, no written informed consent was required for the study. The research complies with the guidelines for human studies and was conducted ethically in accordance with the World Medical Association Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}}]}}